AzTrials
AzTrials

Tobacco Abuse CigaretteHDDNNCT07429825

Effect of a Mobile-Based Anti-Smoking Nursing Intervention on Nursing Students (HDDN)

A study testing HDDN Mobile Application in people with Tobacco Abuse Cigarette, run by LÜTFİYE GÖKÇE at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical trial aims to understand whether a mobile-based anti-smoking nursing intervention can help nursing students change their smoking-related intentions, attitudes, and decision-making. The study focuses on nursing students who currently smoke. Read more about this study

Who is it for?
Ages 17 to 65 years
Conditions the study is for
Tobacco Abuse Cigarette
What is being tested?
HDDN Mobile Application
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2024to 25 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Being an undergraduate student currently enrolled at Ege University Faculty of Nursing
  • Volunteering to participate in the study and providing written informed consent
  • Smoking one or more cigarettes per day
  • Owning a smartphone with either iOS or Android operating system and having regular internet access
  • Having no prior participation in any smoking cessation intervention study

Who cannot join

  • Having previously participated in a smoking cessation intervention program or study
  • Being a non-smoker

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ege University Faculty of Nursing

    Izmir, Bornova, 35100

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Mobile-Based Anti-Smoking Nursing Interventions on Smoking Intention, Attitude, and Decision-Making Balance of Nursing Students

This clinical trial aims to understand whether a mobile-based anti-smoking nursing intervention can help nursing students change their smoking-related intentions, attitudes, and decision-making. The study focuses on nursing students who currently smoke.

The main questions this study aims to answer are:

Read more

Does the mobile-based nursing intervention reduce nursing students' intention to smoke?

Does the intervention change students' attitudes toward smoking?

Does the intervention affect how students weigh the benefits and harms of smoking when making decisions?

Researchers will compare nursing students who receive the mobile-based anti-smoking nursing intervention with students who do not receive this intervention.

Participants will use a mobile application developed by nurses. Through the application, participants will receive structured nursing support related to smoking prevention. Participants will complete questionnaires about their smoking intentions, attitudes, and decision-making at different time points during the study.

Read the detailed description

This study is a randomized controlled clinical trial designed to evaluate the effect of a mobile-based anti-smoking nursing intervention on smoking intention, attitudes toward smoking, and smoking-related decision-making balance among nursing students.

Eligible participants consist of nursing students who currently smoke. Following baseline assessments, participants are randomly assigned to either the intervention group or the control group to ensure comparability between groups at the start of the study.

Participants in the intervention group receive a mobile-based anti-smoking nursing intervention developed within the framework of the nursing process. The intervention is delivered through a structured mobile application and provides planned nursing support aimed at increasing awareness, supporting behavior change, and strengthening smoking-related decision-making. The intervention content is delivered over a defined period and is designed to promote active engagement.

Participants in the control group do not receive the mobile-based nursing intervention and continue under usual conditions throughout the study period.

Data are collected at baseline and at predefined follow-up time points using validated scales and a structured questionnaire. Smoking intention is assessed using the Smoking Intention Questionnaire, attitudes toward smoking are measured with the Smoking Attitudes Scale, and smoking-related decision-making balance is evaluated using the Smoking Decision Balance Scale. Changes over time are analyzed by comparing outcomes between the intervention and control groups.

This study is conducted as part of a doctoral dissertation.

Being tested
HDDN Mobile Application
Keywords
Smoking, Nursing Students, Nursing Care, Public Health Nursing, Mobile Health, mHealth, Behavioral Intervention
Medical subject headings
Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HDDN Mobile ApplicationDevice

    The intervention is a mobile-based nursing intervention designed to prevent smoking and support positive health behavior change among nursing students. It is delivered through a smartphone application compatible with iOS and Android operating systems.

    The intervention includes structured educational modules, motivational messages, and self-monitoring activities focused on smoking-related intention, attitudes, and decision-making balance. Participants receive reminder notifications twice daily during the intervention period. In addition, the application provides nurse-guided support through a messaging feature that allows participants to ask questions and receive guidance.

    The content of the intervention is based on established behavior change theories and is standardized to ensure that all participants receive the same intervention

Study groups in NCT07429825
Study groupRoleWhat they receive
Intervention Group-Mobile-based nursing intervention delivered through the HDDNExperimentalParticipants receive a mobile-based nursing intervention delivered through the HDDN (Hemşire Destekli Dumansız Nefes) mobile application
Receives: Device: HDDN Mobile Application
Control GroupNo interventionParticipants assigned to the control group did not receive any intervention. They continued their usual activities without access to the mobile application or any additional nursing support. Smoking-related attitudes, intentions, and decision-making balance were assessed at baseline, 22 days after baseline, and one month after the first follow-up using self-report questionnaires administered online

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Smoking Intention

    Measured using the Smoking Intention Questionnaire (SIQ). The questionnaire consists of 4 items assessing trying, craving, planning, and thinking. Each item is rated on a 5-point Likert scale (1-5). Total scores range from 4 to 20. Higher scores indicate stronger intention to smoke (worse outcome), whereas lower scores indicate weaker intention to smoke (better outcome).

    Measured: Baseline (Pre-test), 22 days after baseline (1st Follow-up), and 1 month after the first follow-up (2nd Follow-up)

  2. Attitudes toward smoking

    Measured using the Attitudes Toward Smoking Scale. The scale consists of 45 items rated on a 6-point Likert scale (1-6). Total scores range from 45 to 270. Higher scores indicate more positive attitudes toward smoking (worse outcome), whereas lower scores indicate more negative attitudes toward smoking (better outcome).

    Measured: Baseline (Pre-test), 22 days after baseline (1st Follow-up), and 1 month after the first follow-up (2nd Follow-up).

  3. Smoking decision-making balance

    Measured using the Smoking Decisional Balance Scale. The scale consists of 24 items rated on a 5-point Likert scale (1-5), including 11 items assessing perceived benefits of smoking (score range 11-55) and 13 items assessing perceived harms of smoking (score range 13-65). The decisional balance score is calculated by subtracting the perceived harms score from the perceived benefits score. Total scores range from -54 to +42. Positive scores indicate that perceived benefits outweigh harms (worse outcome), whereas negative scores indicate that perceived harms outweigh benefits (better outcome).

    Measured: Baseline (Pre-test), 22 days after baseline (1st Follow-up), and 1 month after the first follow-up (2nd Follow-up).

Secondary outcomes (1)
  1. Smoking Cessation Behavior.

    Percentage of participants who reported "I no longer smoke" for at least 7 days during the 14-day mobile application intervention period, tracked via self-control diaries.

    Measured: During the 14-day intervention period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2026
  2. Study start1 Sep 2024
  3. Primary completion25 Aug 2025
  4. Study completion25 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are assigned to either an intervention group receiving a mobile-based nursing intervention or a control group receiving no intervention. Outcomes are assessed and compared between groups over time.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07429825
Sponsor's protocol ID
YOKTEZ-10755404
Other IDs
TUBITAK PROJECT NO:223S832
Acronym
HDDN
Status last verified
Feb 2026
First submitted
7 Feb 2026
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: To protect the privacy of the participants and comply with the ethical approval conditions, individual participant data (IPD) will not be made publicly available. Study protocols and statistical analysis plans can be shared upon reasonable request to the corresponding author after the study results are published in a peer-reviewed journal.

Questions about this trial

What is this clinical trial studying?

A study testing HDDN Mobile Application in people with Tobacco Abuse Cigarette, run by LÜTFİYE GÖKÇE at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Smoking Intention (time frame: Baseline (Pre-test), 22 days after baseline (1st Follow-up), and 1 month after the first follow-up (2nd Follow-up)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in